NCT07119411 ICU Background Early Awareness for Critical deterioratiON
| NCT ID | NCT07119411 |
| Status | Recruiting |
| Phase | — |
| Sponsor | ETH Zurich |
| Condition | Respiratory Failure |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,962 participants |
| Start Date | 2025-12-01 |
| Primary Completion | 2027-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,962 participants in total. It began in 2025-12-01 with a primary completion date of 2027-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study will compare ICU sub-units, those with additional support of a clinician awareness system, ICU Beacon, and those receiving the standard of care. The win-ratio composite outcome will be assessed by comparing patients by study group and stratified by APACHE score at admission.
Eligibility Criteria
Inclusion Criteria: * admission to intensive care unit Exclusion Criteria: * age \< 18 years * presence of documented refused general consent form (at database closure) * admission for the sole purpose of dying/organ donation or evaluation of such
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07119411 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Respiratory Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07119411 currently recruiting?
Yes, NCT07119411 is actively recruiting participants. Contact the research team at raetsch@ethz.ch for enrollment information.
Where is the NCT07119411 trial being conducted?
This trial is being conducted at Bern, Switzerland.
Who is sponsoring the NCT07119411 clinical trial?
NCT07119411 is sponsored by ETH Zurich. The trial plans to enroll 1,962 participants.